Hints and tips:
Related Topics
...Inc....
...Sequenom was down 2.3 per cent to $2.95 after the biotechnology company said it was co-operating with multiple legal and regulatory probes....
...Sequenom shocked the market by announcing that it had dismissed nearly its entire top management team as a result of a scandal involving the mishandling of data on its pre-natal Down’s syndrome test....
International Edition